Ubs Group Ag Nemaura Medical Inc. Transaction History

Ubs Group Ag

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.15 - $0.34 $2,076 - $4,705	13,841 Added 16283.53%	13,926 $3,000
Q3 2023 Nov 09, 2023	SELL	$0.32 - $1.14 $27 - $96	-85 Reduced 50.0%	85 $0
Q2 2023 Aug 11, 2023	BUY	$0.49 - $0.93 $41 - $79	85 Added 100.0%	170 $0
Q1 2023 May 12, 2023	SELL	$0.71 - $2.86 $3,594 - $14,480	-5,063 Reduced 98.35%	85 $0
Q4 2022 Feb 08, 2023	SELL	$1.72 - $3.13 $1,001 - $1,821	-582 Reduced 10.16%	5,148 $8,000
Q3 2022 Nov 10, 2022	BUY	$1.52 - $2.57 $8,580 - $14,507	5,645 Added 6641.18%	5,730 $12,000
Q1 2022 May 16, 2022	SELL	$3.78 - $4.66 $3,492 - $4,305	-924 Reduced 91.58%	85 $0
Q4 2021 Feb 14, 2022	BUY	$4.12 - $6.35 $3,806 - $5,867	924 Added 1087.06%	1,009 $4,000
Q2 2021 Aug 13, 2021	SELL	$4.7 - $16.7 $2,411 - $8,567	-513 Reduced 85.79%	85 $1,000
Q1 2021 May 12, 2021	SELL	$3.79 - $9.78 $13,587 - $35,061	-3,585 Reduced 85.7%	598 $5,000
Q4 2020 Feb 11, 2021	BUY	$3.47 - $4.52 $14,515 - $18,907	4,183 New	4,183 $16,000
Q3 2020 Nov 12, 2020	SELL	$3.55 - $9.99 $8,236 - $23,176	-2,320 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$4.75 - $15.38 $12,934 - $41,879	-2,723 Reduced 54.0%	2,320 $21,000
Q1 2020 May 01, 2020	BUY	$2.85 - $8.0 $14,372 - $40,344	5,043 New	5,043 $30,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Market Cap $723K
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.